In this platform, morphological analyses were done on hematoxylin and eosin (H&E)-stained slides, and biomarkers (AMACR and AR) were measured from tissue regions defined by AMACR, a heterogeneously expressed marker present in only ~70-90% of prostate cancer patients, and hence not informative in all cases [16]. This evidence concerns the gene AMACR and prostate carcinoma.